Session 3: Methods for Transporter Biomarker Identification, Liquid Biopsy, and Emerging Biomarkers of Efflux Transporters


Back to Package

Co-Chairs: Bhagwat Prasad, Washington State University, Spokane, Washington, USA & Pei Feng Shawn Tan, University of Manchester, Manchester, UK

Use of Metabolomics for Biomarker Identification and Validation

image  Martin Fromm, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlagen, Germany



Isolation of Exosomes/extracellular Vesicles as Biomarkers of Transporter Expression/activity: Challenges, Methodology and Promise

image

 

Brahim Achour, University of Rhode Island, Kingston, Rhode Island, USA




An Update to Existing SLC Biomarkers: Evaluation of the Selectivity of Several OATP1B Biomarkers Using a Relative Activity Factor Method

image

Xiaoyan Chu, Merck, Rahway, New Jersey, USA





Discovery and Validation of Riboflavin as A Surrogate Marker of Breast Cancer Resistance Protein (BCRP)

image



Hong Shen, Bristol Myers Squibb, Princeton, New Jersey, USA




Identification and Evaluation of Biomarkers for BCRP

image


Kathleen Giacomini, University of California San Francisco, San Francisco, California, USA



Roundtable Discussion with Speakers

Key:

Complete
Failed
Available
Locked
Session 3: Methods for Transporter Biomarker Identification, Liquid Biopsy, and Emerging Biomarkers of Efflux Transporters | Introduction
Recorded 03/01/2024  |  3 minutes
Recorded 03/01/2024  |  3 minutes
Session 3: Use of Metabolomics for Biomarker Identification and Validation | Martin Fromm
Recorded 03/01/2024  |  30 minutes
Recorded 03/01/2024  |  30 minutes
Session 3: Isolation of Exosomes/extracellular Vesicles as Biomarkers of Transporter Expression/activity: Challenges, Methodology and Promise | Brahim Achour
Recorded 03/01/2024  |  39 minutes
Recorded 03/01/2024  |  39 minutes
Session 3: An Update to Existing SLC Biomarkers: Evaluation of the Selectivity of Several OATP1B Biomarkers Using a Relative Activity Factor Method | Xiaoyan Chu
Recorded 03/01/2024  |  37 minutes
Recorded 03/01/2024  |  37 minutes
Session 3: Discovery and Validation of Riboflavin as A Surrogate Marker of Breast Cancer Resistance Protein (BCRP) | Hong Shen
Recorded 03/01/2024  |  34 minutes
Recorded 03/01/2024  |  34 minutes
Session 3: Identification and Evaluation of Biomarkers for BCRP | Kathleen Giacomini
Recorded 03/01/2024  |  26 minutes
Recorded 03/01/2024  |  26 minutes
Session 3: Roundtable Discussion with Speakers and Closing
Recorded 03/01/2024  |  43 minutes
Recorded 03/01/2024  |  43 minutes